Claudin-18.2

Claudin-18.2

Claudin-18.2 詳細

Molecule Name
Claudin-18 splice variant 2
分子の別称
Claudin-18.2,CLDN18,Claudin-18
Drug Development Progress
治験薬の数85
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
UNQ778/PRO1572,CLDN18,Claudin 18,Surfactant Associated Protein J,Surfactant, Pulmonary Associated Protein J,Surfactant Associated 5,Claudin-18,SFTA5,SFTPJ,Claudin 18.2,CLDN18.2
バックグランド
Claudins (CLDNs) are a family of proteins that form tight junctions and maintain the polarity of epithelial and endothelial cells. CLDN18 is specifically expressed in the stomach and lung. Of the two CLDN18 isoform transcripts produced by alternative splicing, CLDN18.2 is a highly selective gastric lineage marker that determines the gastric phenotype in a neoplastic condition, whereas CLDN18.1 is lung specific. CLDN18.2 is a highly selective gastric lineage antigen expressed exclusively on short-lived differentiated gastric epithelial cells where it has only limited accessibility to antibody drugs.14,15 CLDN18.2 is maintained during the course of malignant transformation and thus frequently displayed on the surface of human gastric cancer cells.

Claudin-18.2 製品リスト

Species
  • Human / Cynomolgus(6)
  • Human(4)
  • Mouse(2)
Tag
  • -(5)
  • His Tag & Strep Tag(4)
  • His Tag & Flag Tag(2)
  • GFP Tag(1)
Host
  • InsectCells(6)
  • HEK293(5)
  • E. coli(1)
Conjugate
  • Unconjugated(7)
  • Biotin-labeled(3)
  • GFP Fusion(1)
  • PE Labeled(1)
Grade
  • RUO(12)
Low Endotoxin
  • No(12)
You Have Viewed 1-10 Of 12 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

抗体購入プラットフォーム

プロジェクトステージタイプ由来疾患領域適応症
CLDN18.2 CAR-T - 01PhaseICARNanobodySolid TumorAdvanced refractory gastrointestinal tumors
CLDN18.2 VHH - 01LeadMonoclonalNanobodySolid TumorGastric Cancer,Pancreatic cancer
プロジェクト
CLDN18.2 CAR-T - 01
ステージ
PhaseI
タイプ
CAR
由来
Nanobody
疾患領域
Solid Tumor
適応症
Advanced refractory gastrointestinal tumors
プロジェクト
CLDN18.2 VHH - 01
ステージ
Lead
タイプ
Monoclonal
由来
Nanobody
疾患領域
Solid Tumor
適応症
Gastric Cancer,Pancreatic cancer

ライセンシング

プロジェクト薬物タイプ治療分野適応症ステージエリア
Claudin18.2×CD8+ T bsAbBispecific antibodyOncology/CancerGastric cancer,Pancreatic cancer,OophoromaINDGlobal
CLDN 18.2 CAR-TCell therapyOncology/CancerGastric Cancer,Pancreatic CancerINDGlobal
Claudin18.2 mAbMonospecific antibodyOncology/CancerGastric cancerPhase IGlobal
プロジェクト
Claudin18.2×CD8+ T bsAb
薬物タイプ
Bispecific antibody
治療分野
Oncology/Cancer
適応症
Gastric cancer,Pancreatic cancer,Oophoroma
ステージ
IND
エリア
Global
プロジェクト
CLDN 18.2 CAR-T
薬物タイプ
Cell therapy
治療分野
Oncology/Cancer
適応症
Gastric Cancer,Pancreatic Cancer
ステージ
IND
エリア
Global
プロジェクト
Claudin18.2 mAb
薬物タイプ
Monospecific antibody
治療分野
Oncology/Cancer
適応症
Gastric cancer
ステージ
Phase I
エリア
Global
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
OsemitamabMSB-018; TST-001Phase 3 ClinicalHJB (Hangzhou) Co Ltd, Suzhou Transcenta Therapeutics Co Ltd
Biliary Tract Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Gastroesophageal Junction Neoplasms; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
XNW-27011XNW-27011Phase 3 ClinicalEvopoint Biosciences Co Ltd
Adenocarcinoma; Biliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Gastroesophageal Junction Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms
詳細
IMC-002 (Suzhou Immunofoco)IMC-002Phase 3 ClinicalSuzhou Immunofoco Biotechnology Co Ltd
Digestive System Neoplasms; Gastroesophageal Junction Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
詳細
Arcotatug tavatecanIBI-343; IBI343Phase 3 ClinicalInnovent Biologics(Suzhou) Co Ltd
Adenocarcinoma; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
LB-4330LB-4330; Bis-2Phase 3 ClinicalL&L Biopharma Co Ltd
Solid tumours; Uterine Cervical Neoplasms
詳細
JS-107JS-107; JS107Phase 3 ClinicalShanghai Junshi Biosciences Co Ltd
Adenocarcinoma; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
Tecotabart vedotinTPX-4589; BMS-986476; LM-302Phase 3 ClinicalLaNova Medicines Ltd
Adenocarcinoma; Digestive System Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
QLS-31905QLS-31905Phase 3 ClinicalQilu Pharmaceutical Co Ltd
Bile Duct Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
SYSA-1801SYSA1801; CPO-102; EO-3021; SYSA-1801Phase 3 ClinicalCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Digestive System Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
Garetatug RezetecanSHR-A-1904; SHR-A1904Phase 3 ClinicalShanghai Hengrui Pharmaceutical Co Ltd
Bile Duct Neoplasms; Biliary Tract Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Lymphangioma, Cystic; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
FG-M-108FG-M-108; M108; M-108Phase 3 ClinicalFutureGen Biopharm (Beijing) Co Ltd
Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
Sonesitatug VedotinCMG-901; CMG901; AZD-0901; AZD0901Phase 3 ClinicalKeymed Biosciences Co Ltd
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
ASKB-589ASKB-589Phase 3 ClinicalAskGene Pharma Inc, Jiangsu Aosaikang Pharmaceutical Co Ltd
Adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
KD-182KD-182Phase 2 ClinicalNanjing Kaidi Medical Technology Co Ltd
Carcinoma, Pancreatic Ductal; Stomach Neoplasms
詳細
CLDN18.2-TAC T cells TherapyCLDN-18.2-TAC T cells; CLDN18.2-TAC T cellsPhase 2 ClinicalTriumvira Immunologics Inc
Solid tumours; Stomach Neoplasms
詳細
HBM-7022HBM-7022; AZD-5863Phase 2 ClinicalHarbour Biomed
Carcinoma, Pancreatic Ductal; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
詳細
EB-DNK102EB-DNK102Phase 2 ClinicalBeijing Biotech
Carcinoma, Pancreatic Ductal
詳細
Claudin18.2 targeting CAR-T cell therapy (Essen Biotech)Phase 2 ClinicalEssen Biotech
Pancreatic Neoplasms
詳細
AZD-4360AZD4360; AZD-4360Phase 2 ClinicalAstrazeneca Ab
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
詳細
BDC-4182BD-4182; BDC-4182Phase 2 ClinicalBolt Biotherapeutics Inc
Adenocarcinoma; Esophageal Neoplasms; Neoplasms; Stomach Neoplasms
詳細
LCB-02ALCB-02APhase 2 ClinicalLegochem Biosciences Inc
Hematologic Neoplasms; Solid tumours
詳細
PM-1032PM1032; PM-1032Phase 2 ClinicalShanghai Genechem Co Ltd
Neoplasms; Pancreatic Neoplasms
詳細
SpevatamigPT-886; PT886Phase 2 ClinicalPhanes Therapeutics Inc
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
SKB-315SKB-315; SKB315; MK1200; MK-1200Phase 2 ClinicalSichuan Kelun-Biotech Biopharmaceutical Co Ltd
Esophageal Neoplasms; Solid tumours; Stomach Neoplasms
詳細
ATG-022ATG-022; ATN-022Phase 2 ClinicalAntengene Corporation Co Ltd
Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
詳細
SOT-102SOT-102; SOT102; SO-N102Phase 2 ClinicalSotio Biotech AG
Pancreatic Neoplasms; Stomach Neoplasms
詳細
GivastomigTJ-CD4B; ABL-111; TJ-CLDN4B; TJ-033721; TJ-CD4B/ABL111Phase 2 ClinicalI-Mab Biopharma Co Ltd
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours; Stomach Neoplasms
詳細
Q-1802Q-1802Phase 2 ClinicalQure Biotechnology (Shanghai) Co Ltd
Esophageal Neoplasms; Gastrointestinal Neoplasms; Solid tumours
詳細
Recombinant humanized monoclonal antibody MIL93(Mabworks)MIL-93Phase 2 ClinicalBeijing Mabworks Biotech Co Ltd
Gastroesophageal Junction Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
RC-118RC-118; YH005 ADCPhase 2 Clinical
Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
詳細
Recombinant humanized anti-Claudin 18.2 monoclonal antibody (CARsgen)AB-011Phase 1 ClinicalCarsgen Biomedicine (Shanghai) Co Ltd, Kaixing Life Technology (Shanghai) Co Ltd
Esophageal Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
KD-496KD-496(4th); KD-496Phase 1 ClinicalNanjing Kaidi Medical Technology Co Ltd
Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
Claudin18.2 Targeted CAR-T Cells therapy (Frontiergate Biopharm)Phase 1 ClinicalFrontiergate Biopharm (Hainan) Co Ltd
Pancreatic Neoplasms
詳細
Claudin18.2 Targeted Activated Dendritic Cells therapy (Frontiergate Biopharm)Phase 1 ClinicalFrontiergate Biopharm (Hainan) Co Ltd
Pancreatic Neoplasms
詳細
CBG-131CBG-131; CBG131Phase 1 ClinicalCarbiogene Therapeutics Co Ltd
Pancreatic Neoplasms; Stomach Neoplasms
詳細
Claudin18.2 CAR-T cell therapy (Ucello Therapeutics)Phase 1 ClinicalUcello Therapeutics Co Ltd
Solid tumours
詳細
GresonitamabAMG-910Phase 1 ClinicalAmgen Inc
Adenocarcinoma; Esophageal Neoplasms; Stomach Neoplasms
詳細
Claudin18.2-targeted CAR-DCs therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
Colorectal Neoplasms
詳細
Claudin18.2-targeted CAR-T Cells therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
Colorectal Neoplasms
詳細
CT-225XKDCT225; XKDCT-225; CT225Phase 1 ClinicalShenzhen Celconta Life Science Co Ltd
Solid tumours
詳細
SIBP-A18SIBPA18; SIBP-A18Phase 1 ClinicalShanghai Institute of Biological Products Co Ltd
Solid tumours
詳細
[68Ga]Ga-NODAGA-SNA01468Ga-SNA014; [68Ga]Ga-NODAGA-SNA014; SNA-014Phase 1 ClinicalSmartnuclide Biopharma
Adenocarcinoma; Pancreatic Neoplasms
詳細
HD-004HD004; HD-004Phase 1 ClinicalHuadao (Shanghai) Biopharma Co Ltd
Solid tumours
詳細
SPX-102SPX-102Phase 1 ClinicalSparx Therapeutics Inc
Neoplasms
詳細
Cord Blood-Derived CAR-NK Cells therapy (Rongu Biotechnology)CB CAR-NK182; RG-CLDN18.2Phase 1 ClinicalHangzhou Rongu Biotechnology Co Ltd
Pancreatic Neoplasms; Stomach Neoplasms
詳細
LNF-2007LNF-2007; LNF2007Phase 1 ClinicalShandong New Time Pharmaceutical Co Ltd
Solid tumours
詳細
BL-M05D1BL-M05D1; BLM05D1Phase 1 ClinicalSichuan Baili Pharmaceutical Co Ltd, SystImmune
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal adenocarcinoma; Solid tumours; Stomach Neoplasms
詳細
AHT-102AHT102; AHT-102Phase 1 ClinicalGuangxi Lugang Biomedical Technology Co Ltd
Solid tumours
詳細
AZD-6422AZD6422; AZD-6422Phase 1 ClinicalAstrazeneca Plc
Gastrointestinal Neoplasms
詳細
GC-506GC506; GC-506Phase 1 ClinicalGracell Biotechnologies (Shanghai) Co Ltd
Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
詳細
68Ga-PMD22(Peking Union Medical College Hospital)Phase 1 ClinicalPeking Union Medical College Hospital
Gastrointestinal Neoplasms
詳細
AK-132AK132; AK-132Phase 1 Clinical
Neoplasms; Solid tumours
詳細
AHT-101AHT-101; AHT101Phase 1 ClinicalGuangxi Lugang Biomedical Technology Co Ltd
Solid tumours
詳細
TQB-2103TQB2103; TQB-2103Phase 1 ClinicalNanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group
Neoplasms
詳細
BIO-008BIO-008Phase 1 ClinicalShijiazhuang Yiling Pharmaceutical Co Ltd
Solid tumours
詳細
BA-1301BA-1301; BA1301Phase 1 ClinicalShandong Boan Biotechnology Co Ltd
Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
RB-0011RB0011; RB-0011Phase 1 ClinicalRuiyang (Suzhou) Biological Technology Co Ltd
Solid tumours
詳細
LB-1904LB-1904Phase 1 Clinical
Stomach Neoplasms
詳細
Ori-C-613Ori-C-613; OriC-613; Ori-C613Phase 1 ClinicalOriCell Therapeutics Co Ltd
Solid tumours
詳細
CT-048CT-048; KJ-C1807; KJ-C-1807Phase 1 ClinicalCarsgen Biomedicine (Shanghai) Co Ltd
Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
詳細
ASP-2138ASP-2138Phase 1 ClinicalAstellas Pharma Global Development Inc, Xencor Inc
Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
詳細
HEC-016HEC-016Phase 1 ClinicalPeople Hospital Of Luohu,Shenzhen
Esophageal Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
詳細
PM-3023PM-3023Phase 1 Clinical
Solid tumours
詳細
RD-07RD-07Phase 1 ClinicalPeking University
Solid tumours
詳細
IBI-345IBI-345Phase 1 Clinical
Solid tumours
詳細
TORL-2-307-MABTORL-2-307-MABPhase 1 ClinicalTorl Biotherapeutics LLC
Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
TORL-2-307-ADCTORL-2-307-ADCPhase 1 ClinicalTorl Biotherapeutics LLC
Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
BC-008BC-008Phase 1 ClinicalDragonboat Biopharmaceutical
Neoplasms; Solid tumours
詳細
BC-007 (Dragonboat Biopharmaceutical)BC-007Phase 1 ClinicalDragonboat Biopharmaceutical
Neoplasms; Solid tumours
詳細
DR-30303DR-30303Phase 1 ClinicalZhejiang Doer Biologics Corp
Solid tumours
詳細
SG-1906SG-1906; SG1906Phase 1 ClinicalHangzhou Shangjian Biotechnology Co Ltd
Neoplasms; Solid tumours
詳細
BA-1105BA1105; BA-1105Phase 1 ClinicalShandong Boan Biotechnology Co Ltd
Esophageal Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
CLDN 18.2 CAR-T cell therapy (Shanghai Longyao)LY-011Phase 1 ClinicalShanghai Longyao Biological Technology Co Ltd
Pancreatic Neoplasms; Stomach Neoplasms
詳細
IBI-389IBI-389Phase 1 Clinical
Esophageal Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
FL-301NBL-015; FL-301Phase 1 ClinicalNovarock Biotherapeutics Ltd
Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
IBI-360IBI-360Phase 1 Clinical
Neoplasms; Solid tumours
詳細
QL-1779QL-1779; QL1779Phase 1 ClinicalQilu Pharmaceutical Co Ltd
Solid tumours
詳細
LM-102LM-102Phase 1 ClinicalLaNova Medicines Ltd
Biliary Tract Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
HBM-1029HBM-1029; HBM1029Phase 1 ClinicalHarbour Biomed
Esophageal Neoplasms; Solid tumours; Stomach Neoplasms
詳細
LCAR-C18S CAR-T cell therapy (Legend)LB-1908; LCAR-C18S; LCAR-C-18-SPhase 1 Clinical
Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
XKDCT-086XKDCT086; XKDCT-086ClinicalThe Affiliated Hospital Of Qingdao University
Stomach Neoplasms
詳細
CLDN18.2 UCAR-T cell therapyCLDN18.2 UCAR-TClinicalT-Maximum Pharmaceutical (Suzhou) Co Ltd
Stomach Neoplasms
詳細
124I-18B10124I-18B10; 124-I-18-B-10ClinicalBeijing Cancer Hospital, Transcenta Holding Ltd
Gastrointestinal Neoplasms
詳細
CTB-001(Nanjing Bioheng)CTB-001; CTB001ClinicalNanjing Bioheng Biotech Co Ltd
Pancreatic Neoplasms; Stomach Neoplasms
詳細
89Zr-NY00589Zr-NY005ClinicalWuxi Nuoyu Pharmaceutical Technology Co Ltd
Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
ZolbetuximabGC-182; iMAB-362; IMAB-362ApprovedGanymedVyloy, VYLOY, 威络益JapanStomach NeoplasmsAstellas Pharma Inc2024-03-26
Adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Lymphangioma, Cystic; Pain; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
詳細
Customer Reviews